Treating NSCLC Patients Without an Actionable Oncogenic Driver

May 16, 2017
Sarah B. Goldberg, MD, MPH

Sarah B. Goldberg, MD, MPH, assistant professor of Medicine, Yale Cancer Center, discusses treating patients with non-small cell lung cancer (NSCLC) who do not have an actionable oncogenic driver.